FDA Clearance Tracker · P100026-S091
NeuroPace® RNS® System
Last checked: Nov 20, 2026Latest source record: Dec 29, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Dec 29, 2022
Approved
Time to decision
94 days
Received Sep 26, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P100026-S091
- Device name
- NeuroPace® RNS® System
- Applicant
- NeuroPace, Inc.
- Applicant location
- Mountain View, CA
- Received
- Sep 26, 2022
- Decided
- Dec 29, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P100026
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval to use a second contract sterilizer for the ethylene oxide (EO) sterilization of RNS System products.
Source documents
Other decisions for NeuroPace, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.